207 related articles for article (PubMed ID: 17283041)
21. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.
Van den Eertwegh AJ; Noelle RJ; Roy M; Shepherd DM; Aruffo A; Ledbetter JA; Boersma WJ; Claassen E
J Exp Med; 1993 Nov; 178(5):1555-65. PubMed ID: 7693849
[TBL] [Abstract][Full Text] [Related]
22. Myosin IIa Promotes Antibody Responses by Regulating B Cell Activation, Acquisition of Antigen, and Proliferation.
Hoogeboom R; Natkanski EM; Nowosad CR; Malinova D; Menon RP; Casal A; Tolar P
Cell Rep; 2018 May; 23(8):2342-2353. PubMed ID: 29791846
[TBL] [Abstract][Full Text] [Related]
23. The orphan adapter protein SLY1 as a novel anti-apoptotic protein required for thymocyte development.
Reis B; Pfeffer K; Beer-Hammer S
BMC Immunol; 2009 Jul; 10():38. PubMed ID: 19604361
[TBL] [Abstract][Full Text] [Related]
24. Expression of the adaptor protein hematopoietic Src homology 2 is up-regulated in response to stimuli that promote survival and differentiation of B cells.
Herrin BR; Justement LB
J Immunol; 2006 Apr; 176(7):4163-72. PubMed ID: 16547253
[TBL] [Abstract][Full Text] [Related]
25. Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development.
Clements JL; Yang B; Ross-Barta SE; Eliason SL; Hrstka RF; Williamson RA; Koretzky GA
Science; 1998 Jul; 281(5375):416-9. PubMed ID: 9665885
[TBL] [Abstract][Full Text] [Related]
26. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
27. Abl-SH3 binding protein 2, 3BP2, interacts with CIN85 and HIP-55.
Le Bras S; Moon C; Foucault I; Breittmayer JP; Deckert M
FEBS Lett; 2007 Mar; 581(5):967-74. PubMed ID: 17306257
[TBL] [Abstract][Full Text] [Related]
28. The endocytic adaptor Eps15 controls marginal zone B cell numbers.
Pozzi B; Amodio S; Lucano C; Sciullo A; Ronzoni S; Castelletti D; Adler T; Treise I; Betsholtz IH; Rathkolb B; Busch DH; Wolf E; Fuchs H; Gailus-Durner V; de Angelis MH; Betsholtz C; Casola S; Di Fiore PP; Offenhäuser N
PLoS One; 2012; 7(11):e50818. PubMed ID: 23226392
[TBL] [Abstract][Full Text] [Related]
29. SYK-3BP2 Pathway Activity in Parenchymal and Myeloid Cells Is a Key Pathogenic Factor in Metabolic Steatohepatitis.
Luci C; Vieira E; Bourinet M; Rousseau D; Bonnafous S; Patouraux S; Lefevre L; Larbret F; Prod'homme V; Iannelli A; Tran A; Anty R; Bailly-Maitre B; Deckert M; Gual P
Cell Mol Gastroenterol Hepatol; 2022; 13(1):173-191. PubMed ID: 34411785
[TBL] [Abstract][Full Text] [Related]
30. Rapid induction of splenic and peritoneal B-1a cells in adult mice by thymus-independent type-2 antigen.
Whitmore AC; Neely HR; Diz R; Flood PM
J Immunol; 2004 Nov; 173(9):5406-14. PubMed ID: 15494487
[TBL] [Abstract][Full Text] [Related]
31. Increase of CD5(+) B cells during adolescence in female mice.
Watanabe K; Watanabe M; Maruoka H; Amino N; Iwatani Y
Mech Ageing Dev; 2001 Oct; 122(15):1787-95. PubMed ID: 11557280
[TBL] [Abstract][Full Text] [Related]
32. Dok-1 and Dok-2 are negative regulators of T cell receptor signaling.
Yasuda T; Bundo K; Hino A; Honda K; Inoue A; Shirakata M; Osawa M; Tamura T; Nariuchi H; Oda H; Yamamoto T; Yamanashi Y
Int Immunol; 2007 Apr; 19(4):487-95. PubMed ID: 17329234
[TBL] [Abstract][Full Text] [Related]
33. Humoral immune responses in humanized BLT mice immunized with West Nile virus and HIV-1 envelope proteins are largely mediated via human CD5+ B cells.
Biswas S; Chang H; Sarkis PT; Fikrig E; Zhu Q; Marasco WA
Immunology; 2011 Dec; 134(4):419-33. PubMed ID: 22044090
[TBL] [Abstract][Full Text] [Related]
34. 3BP2-deficient mice are osteoporotic with impaired osteoblast and osteoclast functions.
Levaot N; Simoncic PD; Dimitriou ID; Scotter A; La Rose J; Ng AH; Willett TL; Wang CJ; Janmohamed S; Grynpas M; Reichenberger E; Rottapel R
J Clin Invest; 2011 Aug; 121(8):3244-57. PubMed ID: 21765218
[TBL] [Abstract][Full Text] [Related]
35. The adaptor protein Sh2d3c is critical for marginal zone B cell development and function.
Al-Shami A; Wilkins C; Crisostomo J; Seshasayee D; Martin F; Xu N; Suwanichkul A; Anderson SJ; Oravecz T
J Immunol; 2010 Jul; 185(1):327-34. PubMed ID: 20505138
[TBL] [Abstract][Full Text] [Related]
36. Bone dynamics and inflammation: lessons from rare diseases.
Matsumoto Y; Rottapel R
Immunol Med; 2020 Jun; 43(2):61-64. PubMed ID: 31999934
[TBL] [Abstract][Full Text] [Related]
37. Signaling of the ITK (interleukin 2-inducible T cell kinase)-SYK (spleen tyrosine kinase) fusion kinase is dependent on adapter SLP-76 and on the adapter function of the kinases SYK and ZAP70.
Hussain A; Mohammad DK; Gustafsson MO; Uslu M; Hamasy A; Nore BF; Mohamed AJ; Smith CI
J Biol Chem; 2013 Mar; 288(10):7338-50. PubMed ID: 23293025
[TBL] [Abstract][Full Text] [Related]
38. Immature hematopoietic cells display selective requirements for adhesion- and degranulation-promoting adaptor protein in development and homeostatsis.
Dluzniewska J; Zou L; Harmon IR; Ellingson MT; Peterson EJ
Eur J Immunol; 2007 Nov; 37(11):3208-19. PubMed ID: 17948263
[TBL] [Abstract][Full Text] [Related]
39. Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.
Levaot N; Voytyuk O; Dimitriou I; Sircoulomb F; Chandrakumar A; Deckert M; Krzyzanowski PM; Scotter A; Gu S; Janmohamed S; Cong F; Simoncic PD; Ueki Y; La Rose J; Rottapel R
Cell; 2011 Dec; 147(6):1324-39. PubMed ID: 22153076
[TBL] [Abstract][Full Text] [Related]
40. Adaptor protein 3BP2 is a potential ligand of Src homology 2 and 3 domains of Lyn protein-tyrosine kinase.
Maeno K; Sada K; Kyo S; Miah SM; Kawauchi-Kamata K; Qu X; Shi Y; Yamamura H
J Biol Chem; 2003 Jul; 278(27):24912-20. PubMed ID: 12709437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
